1 May 2025

Last updated: Tuesday 29 April 2025

Research Directory

Drug development robust, despite the pandemic

A record year for the financing of ATMPs

Top 10 financing events for ATMPs in 2020

Low interest rates, vaccines carry stock values higher

Developing radionuclide PARP inhibitors

The linker matters in antibody-drug conjugates

Real world evidence is changing regulatory policy

The hunt for the perfect tumour-associated antigen

New treatments for amyotrophic lateral sclerosis

Using wastewater surveillance to control Covid-19